Trial Profile
A Phase 1 trial of ACT-774312
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2017
Price :
$35
*
At a glance
- Drugs ACT 774312 (Primary)
- Indications Asthma
- Focus Adverse reactions
- 01 Jun 2017 New trial record